ProfileGDS4132 / 220723_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 22% 22% 24% 21% 21% 19% 19% 17% 21% 22% 19% 25% 22% 14% 16% 20% 16% 22% 22% 23% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10150.617322
GSM201543Muscle PCOS pioglitazone 12141.91722
GSM201544Muscle PCOS pioglitazone 16158.3124
GSM201545Muscle PCOS pioglitazone 20154.717321
GSM201829Muscle PCOS pioglitazone 23149.977621
GSM201830Muscle PCOS pioglitazon 25142.452219
GSM201831Muscle PCOS pioglitazone 27138.846319
GSM201832Muscle PCOS pioglitazone 3137.374817
GSM201833Muscle PCOS pioglitazone 4145.010921
GSM201834Muscle PCOS pioglitazone 8148.36722
GSM201835Muscle PCOS after pioglitazone 10232.069519
GSM201836Muscle PCOS after pioglitazone 12249.848525
GSM201837Muscle PCOS after pioglitazone 16239.168922
GSM201838Muscle PCOS after pioglitazone 20224.660814
GSM201839Muscle PCOS after pioglitazone 23228.556116
GSM201840Muscle PCOS after pioglitazone 25243.42820
GSM201841Muscle PCOS after pioglitazone 27225.807916
GSM201842Muscle PCOS after pioglitazone 3239.457722
GSM201843Muscle PCOS after pioglitazone 4248.930222
GSM201844Muscle PCOS after pioglitazone 8249.264523